| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-07 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-07 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.23 |
9e-06 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.22 |
2e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.22 |
3e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |